178 related articles for article (PubMed ID: 28401485)
21. Silibinin-induced glioma cell apoptosis by PI3K-mediated but Akt-independent downregulation of FoxM1 expression.
Zhang M; Liu Y; Gao Y; Li S
Eur J Pharmacol; 2015 Oct; 765():346-54. PubMed ID: 26342429
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
[TBL] [Abstract][Full Text] [Related]
23. Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468.
Abdollahi P; Ebrahimi M; Motamed N; Samani FS
Anticancer Drugs; 2015 Jun; 26(5):487-97. PubMed ID: 25603020
[TBL] [Abstract][Full Text] [Related]
24. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
Singh RP; Dhanalakshmi S; Agarwal C; Agarwal R
Oncogene; 2005 Feb; 24(7):1188-202. PubMed ID: 15558015
[TBL] [Abstract][Full Text] [Related]
25. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells.
Sharma G; Singh RP; Chan DC; Agarwal R
Anticancer Res; 2003; 23(3B):2649-55. PubMed ID: 12894553
[TBL] [Abstract][Full Text] [Related]
26. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
Bhatia N; Agarwal C; Agarwal R
Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
[TBL] [Abstract][Full Text] [Related]
27. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway.
Chen PN; Hsieh YS; Chiang CL; Chiou HL; Yang SF; Chu SC
J Dent Res; 2006 Mar; 85(3):220-5. PubMed ID: 16498067
[TBL] [Abstract][Full Text] [Related]
28. Convallaria keiskei as a novel therapeutic alternative for salivary gland cancer treatment by targeting myeloid cell leukemia-1.
Lee HE; Nam JS; Shin JA; Hong IS; Yang IH; You MJ; Cho SD
Head Neck; 2016 Apr; 38 Suppl 1():E761-70. PubMed ID: 25914292
[TBL] [Abstract][Full Text] [Related]
29. Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells.
Kim SH; Kim KY; Yu SN; Park SK; Choi HD; Ji JH; Ahn SC
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):151-6. PubMed ID: 26522224
[TBL] [Abstract][Full Text] [Related]
30. Silymarin versus Silibinin: Differential Antioxidant and Neuroprotective Effects against H2O2-induced Oxidative Stress in PC12 Cells.
Jiang HH; Yan FS; Shen L; Ji HF
Nat Prod Commun; 2016 May; 11(5):633-6. PubMed ID: 27319137
[TBL] [Abstract][Full Text] [Related]
31. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
32. Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.
Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
Oncogene; 2002 Mar; 21(11):1759-67. PubMed ID: 11896607
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide (•NO) generation but not ROS plays a major role in silibinin-induced autophagic and apoptotic death in human epidermoid carcinoma A431 cells.
Yu Y; Fan SM; Yuan SJ; Tashiro S; Onodera S; Ikejima T
Free Radic Res; 2012 Nov; 46(11):1346-60. PubMed ID: 22861160
[TBL] [Abstract][Full Text] [Related]
34. ERα down-regulation plays a key role in silibinin-induced autophagy and apoptosis in human breast cancer MCF-7 cells.
Zheng N; Zhang P; Huang H; Liu W; Hayashi T; Zang L; Zhang Y; Liu L; Xia M; Tashiro S; Onodera S; Ikejima T
J Pharmacol Sci; 2015 Jul; 128(3):97-107. PubMed ID: 26117209
[TBL] [Abstract][Full Text] [Related]
35. Silibinin, a natural flavonoid, induces autophagy via ROS-dependent mitochondrial dysfunction and loss of ATP involving BNIP3 in human MCF7 breast cancer cells.
Jiang K; Wang W; Jin X; Wang Z; Ji Z; Meng G
Oncol Rep; 2015 Jun; 33(6):2711-8. PubMed ID: 25891311
[TBL] [Abstract][Full Text] [Related]
36. Silibinin induces apoptosis through inhibition of the mTOR-GLI1-BCL2 pathway in renal cell carcinoma.
Ma Z; Liu W; Zeng J; Zhou J; Guo P; Xie H; Yang Z; Zheng L; Xu S; Wang X; Chang LS; He D; Li L
Oncol Rep; 2015 Nov; 34(5):2461-8. PubMed ID: 26323996
[TBL] [Abstract][Full Text] [Related]
37. Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.
Tyagi A; Agarwal C; Dwyer-Nield LD; Singh RP; Malkinson AM; Agarwal R
Mol Carcinog; 2012 Oct; 51(10):832-42. PubMed ID: 21882257
[TBL] [Abstract][Full Text] [Related]
38. Silibinin triggers apoptosis and cell-cycle arrest of SGC7901 cells.
Zhang Y; Li Q; Ge Y; Chen Y; Chen J; Dong Y; Shi W
Phytother Res; 2013 Mar; 27(3):397-403. PubMed ID: 22619007
[TBL] [Abstract][Full Text] [Related]
39. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma.
Li L; Gao Y; Zhang L; Zeng J; He D; Sun Y
Cancer Lett; 2008 Dec; 272(1):61-9. PubMed ID: 18723275
[TBL] [Abstract][Full Text] [Related]
40. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line.
Bang CI; Paik SY; Sun DI; Joo YH; Kim MS
Ann Otol Rhinol Laryngol; 2008 Oct; 117(10):781-5. PubMed ID: 18998509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
